Roland Levandowski
Food and Drug Administration
6 Papers
127 Citations
Roland Levandowski is an academic researcher from Food and Drug Administration. The author has contributed to research in topics: Vaccination & M1 protein. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
Effect of Influenza Virus Matrix Protein and Viral RNA on Ribonucleoprotein Formation and Nuclear Export
TL;DR: It is demonstrated for the first time that vRNA and M1 together promote the self-assembly of influenza virus NP into the quaternary helical structure typical of the viral RNP.
72
Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults.
John J. Treanor,Wendy A. Keitel,Robert B. Belshe,James D. Campbell,Gilbert M. Schiff,Kenneth M. Zangwill,Mark Wolff,Alexander Klimov,Roland Levandowski,Linda C. Lambert +9 more
TL;DR: The results suggest that when vaccine is in short supply, a strategy using a half dose in healthy adults could increase the number of people vaccinated with relatively little adverse impact on vaccine immunogenicity.
67
Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010: Improving influenza vaccine virus selection
William Ampofo,Norman Baylor,Sarah Cobey,Nancy J. Cox,Sharon Daves,Steven Edwards,Neil M. Ferguson,Gary Grohmann,Alan J. Hay,Jacqueline M. Katz,Kornnika Kullabutr,Linda C. Lambert,Roland Levandowski,Akhilesh C. Mishra,Arnold S. Monto,Marilda M. Siqueira,Masato Tashiro,Anthony L. Waddell,Niteen Wairagkar,John Wood,Maria Zambon,Wenqing Zhang +21 more
TL;DR: The expanded and enhanced role of the GISRS, recognition of the continuing threat posed by avian H5N1 and the aftermath of the 2009 H1N1 pandemic provide an opportune time to critically review the process by which influenza vaccine viruses are selected, and to promote greater appreciation by the wider influenza and policy‐making community of the complexity of influenza vaccine virus selection.
66
Annual influenza vaccination: immune response in patients over 10 years.
Peter A. Gross,Carolyn R. Denning,Carolyn R. Denning,Pureza F. Gaerlan,Pureza F. Gaerlan,Joan Bonelli,Joan Bonelli,Maureen Bernius,Maureen Bernius,Sandra Dran,Sandra Dran,Gary Monk,Gary Monk,Mary Vassallo,Mary Vassallo,Gerald V. Quinnan,Gerald V. Quinnan,Roland Levandowski,P Cataruozolo,P Cataruozolo,Sylvan Wallenstein +20 more
TL;DR: Annual influenza vaccination appears to regularly induce presumably protective serum antibody levels in most CF children and young adults studied over a 10 year period.
37
Genetic and phenotypic analysis of reassortants of high growth and low growth strains of influenza B virus
TL;DR: The studies identify multiple genes that may affect growth of influenza B viruses in eggs by analysis of the deduced amino acid (AA) sequences of four genes: NS (NS1, NS2), M (BM2), NA (NA, NB) and PB1.
21